4//SEC Filing
MOLLOY ANTHONY 4
Accession 0001209191-22-023856
CIK 0001396814other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:16 PM ET
Size
25.0 KB
Accession
0001209191-22-023856
Insider Transaction Report
Form 4
MOLLOY ANTHONY
Chief Lgl & Compliance Officer
Transactions
- Exercise/Conversion
Common Stock
2022-04-06$38.35/sh+7,000$268,450→ 40,050 total - Exercise/Conversion
Common Stock
2022-04-06$40.34/sh+3,000$121,020→ 20,550 total - Exercise/Conversion
Common Stock
2022-04-06$44.20/sh+10,000$442,000→ 30,550 total - Exercise/Conversion
Common Stock
2022-04-06$34.38/sh+2,500$85,938→ 33,050 total - Sale
Common Stock
2022-04-06$76.03/sh−16,060$1,221,042→ 23,990 total - Sale
Common Stock
2022-04-06$77.03/sh−3,937$303,267→ 20,053 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-04-06−3,000→ 0 totalExercise: $40.34Exp: 2026-06-15→ Common Stock (3,000 underlying) - Sale
Common Stock
2022-04-06$77.94/sh−2,503$195,084→ 17,550 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-04-06−10,000→ 0 totalExercise: $44.20Exp: 2027-06-14→ Common Stock (10,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-04-06−2,500→ 625 totalExercise: $34.38Exp: 2028-05-02→ Common Stock (2,500 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-04-06−7,000→ 1,750 totalExercise: $38.35Exp: 2028-06-13→ Common Stock (7,000 underlying)
Footnotes (6)
- [F1]The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.55 to $76.53, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.58 to $77.57, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.585 to $78.490, inclusive.
- [F5]The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remained in continuous service with the issuer as of each vesting date.
- [F6]The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001900012
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 4:16 PM ET
- Size
- 25.0 KB